Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
umbilical cord mesenchymal stem cells (Zhejiang Gene Stem Cell Biotech)
- Development stage
- Preclinical
- Lead developer
- Zhejiang Gene Stem Cell Biotech
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous, Implant, Intrathecal
01
Overview
Umbilical cord mesenchymal stem cells (UC-MSCs) are multipotent stromal cells derived from the Wharton's jelly of the human umbilical cord. These cells possess significant immunomodulatory, anti-inflammatory, and pro-regenerative properties, making them a versatile candidate for various degenerative and inflammatory conditions. Zhejiang Gene Stem Cell Biotech is developing UC-MSC therapies for a range of indications, including ischemic and hemorrhagic stroke, refractory epilepsy, and severe chronic radiation enteritis. Notably, they are also investigating a combination of UC-MSCs with a collagen scaffold for the treatment of thin endometrium and reproductive organ dysfunction. These programs are currently categorized as clinical research projects approved by the Chinese National Health Commission and the Ministry of Science and Technology, often conducted in collaboration with clinical centers such as Shanghai Tenth People's Hospital.
- Other names
- umbilical cord MSChUC-MSChuman umbilical cord mesenchymal stem cellsUC-MSC
Beyond the preview
Go deeper on umbilical cord mesenchymal stem cells (Zhejiang Gene Stem Cell Biotech).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on umbilical cord mesenchymal stem cells (Zhejiang Gene Stem Cell Biotech).